摘要
目的合成可溶性HLA-G1-肽复合物。方法利用原核高效表达的可溶性HLA-G1重链和轻链(β2m),在人工合成的HLA-G1限制性九肽(KGPPAALTL)存在的条件下,通过稀释复性折叠成可溶性HLA-G1-肽复合物。利用特异性抗体(W6/32及兔抗人β2m抗体)进行免疫印迹及酶联免疫吸附试验,检测稀释复性的折叠产物。结果折叠复合物含有35%可溶性HLA-G1-肽复合物、5%可溶性HLA-G1重链聚合体及60%复性的β2m3种成分。结论通过原核表达、体外折叠能够获得大量可溶性HLA-G1-肽复合物。
Objective To refold soluble HLA-Gl-peptide complex in vitro. Methods The heavy chain of soluble HLA-G1 and β2m were high-level expressed as insoluble aggregates in E, ooli, and then the two subunits were refolded to form a sHL-A-G1-peptide complex by dilution method in the presence of a synthesized nonapeptide (KGPPAALTL). The refolded product was detected by ELISA and Westem blot with mAb W6/32 and rabbit anti-humaβ2m antibody. Results The refo[ded complex was complesed of 35% sHLA-G1-peptide complex, 5% soluble heavy chain aggregate and 60% refolded β2m. Conclusion The refolding of sHLA G1 peptide complex can be successfully generated with Prokaryotie expressing and Refolding in vitro.
出处
《华中医学杂志》
CAS
2006年第1期7-9,共3页
Central China Medical Journal
基金
国家自然科学基金资助项目(No.30271201)
科技部973计划资助课题(No.2001CB510008)。